✦ LIBER ✦

7013 Phase II trial of the specific endothelin A receptor antagonist zibotentan (ZD4054) in pain-free or mildly symptomatic patients with hormone-resistant prostate cancer and bone metastases: final analysis of safety and efficacy

✍ Scribed by James, N.D.; Morris, T.; Phung, D.; McIntosh, S.; Dawson, N.A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Final safety and efficacy analysis of th

✍ Nicholas D. James; Armelle Caty; Heather Payne; Michael Borre; Bernard A. Zonnen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB

Safety and Efficacy of the Specific Endo

✍ Nicholas D. James; Armelle Caty; Michael Borre; Bernard A. Zonnenberg; Philippe 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 1000 KB

Health-related quality of life in pain-f

✍ Nancy Dawson; Heather Payne; Clare Battersby; Maria Taboada; Nick James 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 375 KB

3LB ZD4054, a potent, specific endotheli

✍ N.D. James; M. Borre; B. Zonnenberg; P. Beuzeboc; T. Morris; D. Phung; N. Dawson 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 38 KB

50 QUALITY OF LIFE IN A RANDOMIZED PLACE

✍ H. Payne; C. Battersby; S. Hughes; M. Taboada; N.D. James 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 518 KB